The development of prostate cancer despite late onset androgen deficiency

Shomik Sengupta, Henry J. Duncan, Robert J. Macgregor, John M. Russell

Research output: Contribution to journalArticleOtherpeer-review

8 Citations (Scopus)

Abstract

Androgen withdrawal causes the regression of prostate cancer and is used in therapy, but the role of androgens in the development of prostate cancer is uncertain. We present a case of prostate cancer diagnosed in a man who had been clinically androgen deficient for some years. This case and reviewed literature suggest that while early androgen exposure may be important in the prostatic carcinogenesis, late onset androgen deficiency is not protective. Thus, hypogonadal men considering androgen replacement therapy need to be adequately counseled, screened for prostate cancer and followed closely during treatment.

Original languageEnglish
Pages (from-to)847-848
Number of pages2
JournalInternational Journal of Urology
Volume12
Issue number9
DOIs
Publication statusPublished - 1 Sep 2005
Externally publishedYes

Keywords

  • Androgens
  • Hormone replacement therapy
  • Hypogonadism
  • Prostate cancer
  • Prostate-specific antigen

Cite this